ISIN | CH0586376979 |
---|---|
Valor Number | 58637697 |
Bloomberg Global ID | |
Fund Name | acrevis spektrum Fund Aktien Schweiz Pt |
Fund Provider |
acrevis Bank AG
St. Gallen, Switzerland Phone: +41 58 122 75 55 E-Mail: info@acrevis.ch Web: www.acrevis.ch |
Fund Provider | acrevis Bank AG |
Representative in Switzerland | |
Distributor(s) |
acrevis Bank AG St. Gallen |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | Das Anlageziel besteht hauptsächlich darin, einen langfristigen Kapitalzuwachs verbunden mit angemessenen Erträgen zu erzielen und die Performance des im Anhang erwähnten Referenzindex (nachfolgend "Referenzindex") durch aktives Management zu übertreffen, wobei von Anlagen im Referenzindex abgewichen werden kann. |
Peculiarities |
Current Price * | 105.77 CHF | 19.12.2024 |
---|---|---|
Previous Price * | 108.17 CHF | 18.12.2024 |
52 Week High * | 116.16 CHF | 30.08.2024 |
52 Week Low * | 100.12 CHF | 17.01.2024 |
NAV * | 105.77 CHF | 19.12.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 151,769,708 | |
Unit/Share Assets *** | 218,152 | |
Trading Information SIX |
YTD Performance | +4.90% |
29.12.2023 - 19.12.2024
29.12.2023 19.12.2024 |
---|---|---|
1 month | -0.91% |
19.11.2024 - 19.12.2024
19.11.2024 19.12.2024 |
3 months | -6.47% |
19.09.2024 - 19.12.2024
19.09.2024 19.12.2024 |
6 months | -6.17% |
19.06.2024 - 19.12.2024
19.06.2024 19.12.2024 |
1 year | +4.76% |
19.12.2023 - 19.12.2024
19.12.2023 19.12.2024 |
2 years | +13.54% |
19.12.2022 - 19.12.2024
19.12.2022 19.12.2024 |
3 years | -6.34% |
20.12.2021 - 19.12.2024
20.12.2021 19.12.2024 |
5 years | +7.05% |
16.03.2021 - 19.12.2024
16.03.2021 19.12.2024 |
Equity Participation Rate in % | 99.59 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 11.97% | |
---|---|---|
Nestle SA | 11.43% | |
Roche Holding AG | 10.66% | |
ABB Ltd | 5.85% | |
Zurich Insurance Group AG | 5.74% | |
Lonza Group Ltd | 5.43% | |
Swiss Life Holding AG | 4.77% | |
Compagnie Financiere Richemont SA Class A | 4.22% | |
Logitech International SA | 3.60% | |
Holcim Ltd | 3.42% | |
Last data update | 30.11.2024 |
TER | 0.90% |
---|---|
TER date | 31.10.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 30.11.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |